The University of Southampton
University of Southampton Institutional Repository

Point-of-care testing of procalcitonin using lateral flow assay

Point-of-care testing of procalcitonin using lateral flow assay
Point-of-care testing of procalcitonin using lateral flow assay

This study presents a novel gold nano shells (GNS)-assisted paper-based lateral flow assay (LFA) for the detection of procalcitonin (PCT). PCT is a biomarker of infection, originating from the C cells of the thyroid gland and functioning as a precursor to the hormone calcitonin. Its concentration in the blood is known to increase in line with the progression of infectious diseases. Conventional techniques for assessing PCT levels in the blood encompass culture-based methods, enzyme-linked immunosorbent assay (ELISA) and electrochemical immunoassays. These methods are characterized by either prolonged processing times, high costs, or dependence on laboratory infrastructure. These limitations hinder their practical implementation in point-of-care settings. As a result, the development of a LFA for detecting PCT levels proves to be well-suited for point-of-care settings, serving as a valuable diagnostic tool for infectious diseases. This study focuses on comparing the efficacy of GNS and gold nanoparticle (GNP)-assisted lateral flow assays (LFA) to ascertain the lower limit of detection (LOD) for PCT and assess their overall reliability. Our findings indicate that GNS-assisted LFA achieved a lower LOD of 1 ng/mL, surpassing GNP, which exhibited a LOD of 5 ng/mL. Furthermore, outstanding specificity was demonstrated and clinical application capability in human serum was confirmed, reinforcing its efficacy as a reliable platform.Clinical

1557-170X
IEEE
Deodhar, Jovita Rajesh
00d58487-d17e-4196-bf13-8a23914bf263
Zhang, Chengchen
abc47c06-4b99-4aed-be72-463f211e9dfa
Guo, Tianruo
a9cd6c53-2664-4bd3-8021-576cd53cdaaf
Xue, Ruier
da150847-d5f9-46fe-9ddb-428c7d9a4b94
Shivdasani, Mohit N.
5d812a52-88f1-4424-9d71-39983dd59ae5
Deng, Fei
426fa10e-62cf-4593-b476-160aa39a8ece
Deodhar, Jovita Rajesh
00d58487-d17e-4196-bf13-8a23914bf263
Zhang, Chengchen
abc47c06-4b99-4aed-be72-463f211e9dfa
Guo, Tianruo
a9cd6c53-2664-4bd3-8021-576cd53cdaaf
Xue, Ruier
da150847-d5f9-46fe-9ddb-428c7d9a4b94
Shivdasani, Mohit N.
5d812a52-88f1-4424-9d71-39983dd59ae5
Deng, Fei
426fa10e-62cf-4593-b476-160aa39a8ece

Deodhar, Jovita Rajesh, Zhang, Chengchen, Guo, Tianruo, Xue, Ruier, Shivdasani, Mohit N. and Deng, Fei (2024) Point-of-care testing of procalcitonin using lateral flow assay. In 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2024 - Proceedings. IEEE. 4 pp . (doi:10.1109/EMBC53108.2024.10782080).

Record type: Conference or Workshop Item (Paper)

Abstract

This study presents a novel gold nano shells (GNS)-assisted paper-based lateral flow assay (LFA) for the detection of procalcitonin (PCT). PCT is a biomarker of infection, originating from the C cells of the thyroid gland and functioning as a precursor to the hormone calcitonin. Its concentration in the blood is known to increase in line with the progression of infectious diseases. Conventional techniques for assessing PCT levels in the blood encompass culture-based methods, enzyme-linked immunosorbent assay (ELISA) and electrochemical immunoassays. These methods are characterized by either prolonged processing times, high costs, or dependence on laboratory infrastructure. These limitations hinder their practical implementation in point-of-care settings. As a result, the development of a LFA for detecting PCT levels proves to be well-suited for point-of-care settings, serving as a valuable diagnostic tool for infectious diseases. This study focuses on comparing the efficacy of GNS and gold nanoparticle (GNP)-assisted lateral flow assays (LFA) to ascertain the lower limit of detection (LOD) for PCT and assess their overall reliability. Our findings indicate that GNS-assisted LFA achieved a lower LOD of 1 ng/mL, surpassing GNP, which exhibited a LOD of 5 ng/mL. Furthermore, outstanding specificity was demonstrated and clinical application capability in human serum was confirmed, reinforcing its efficacy as a reliable platform.Clinical

This record has no associated files available for download.

More information

Published date: 17 December 2024
Venue - Dates: 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2024, , Orlando, United States, 2024-07-15 - 2024-07-19

Identifiers

Local EPrints ID: 503174
URI: http://eprints.soton.ac.uk/id/eprint/503174
ISSN: 1557-170X
PURE UUID: 28941d24-d478-4b65-9ef6-ec2127cf97b7
ORCID for Chengchen Zhang: ORCID iD orcid.org/0000-0001-8802-539X

Catalogue record

Date deposited: 23 Jul 2025 16:36
Last modified: 24 Jul 2025 02:08

Export record

Altmetrics

Contributors

Author: Jovita Rajesh Deodhar
Author: Chengchen Zhang ORCID iD
Author: Tianruo Guo
Author: Ruier Xue
Author: Mohit N. Shivdasani
Author: Fei Deng

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×